Attendance at supervised injecting facilities and use of detoxification services [17]

New England Journal of Medicine

Volumn 354, Issue 23, 2006, Pages 2512-2514

  Wood, Evan ^a   Tyndall, Mark W ^a   Zhang, Ruth ^b   Stoltz, Jo Anne ^b   Lai, Calvin ^b   Montaner, Julio S G ^a   Kerr, Thomas ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

CANADA; DETOXIFICATION; DRUG DEPENDENCE; FOLLOW UP; HUMAN; LETTER; METHODOLOGY; NORTH AMERICA; PRIORITY JOURNAL; QUESTIONNAIRE;

CANADA; HARM REDUCTION; HUMANS; NEEDLE-EXCHANGE PROGRAMS; PROPORTIONAL HAZARDS MODELS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33744957164     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc052939     Document Type: Letter

References (5)

1. Kerr T, Tyndall M, Li K, Montaner JS, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005;366:316-8.
2. Gandey A. US slams Canada over Vancouver's new drug injection site. CMAJ 2003;169:1063.
3. Yamey G. UN condemns Australian plans for "safe injecting rooms." BMJ 2000;320:667.
4. Wood E, Kerr T, Lloyd-Smith E, et al. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J 2004;1:9.
5. Wood E, Tyndall MW, Li K, et al. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med 2005;29:126-30.